X-ray crystal structure of 28-O-methylrapamycin complexed with FKBP12: Is the cyclohexyl moiety part of the effector domain of rapamycin?

Journal of the American Chemical Society

Volumn 118, Issue 25, 1996, Pages 5857-5861

  Kallen, Joerg A ^a   Sedrani, Richard ^a   Cottens, Sylvain ^a  

^a Preclinical Research   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

28 O METHYLRAPAMYCIN; BINDING PROTEIN; FK 506 BINDING PROTEIN; RAPAMYCIN; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; IN VITRO STUDY; X RAY CRYSTALLOGRAPHY;

EID: 0030054923     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja954328h     Document Type: Article

References (49)

1. (1)(a) Vézina, C.; Kudelski, A.; Sehgal, S. N. J. Antibiot. 1975, 28, 721-726.
2. (b) Sehgal, S. N.; Baker, H.; Vézina, C. J. Antibiot. 1975, 28, 727-732.
3. Martel, R. R.; Klicius, J.; Galet, S. Can. J. Physiol. Pharmacol. 1977, 55, 48-51.
4. (a) Caufield, C. E.; Musser, J. H. Annual Reports in Medicinal Chemistry; Bristol, J. A., Ed.; Academic Press, Inc.: San Diego, 1990; Vol. 25, pp 195-204.
5. (b) Luly, J. R. Annual Reports in Medicinal Chemistry; Bristol, J. A., Ed.; Academic Press, Inc.: San Diego, 1991; Vol. 26, pp 211-220.
6. (c) Morris, R. E. J. Heart Lung Transplant. 1993, 12, S275-S286.
7. (d) Sehgal, S. N.; Molnar-Kimber, K.; Ocain, T. D.; Weichman, B. M. Med. Res. Rev. 1994, 14, 1-22.
8. (e) Kahan, B. D.; Chou, T.; Tejpal, N.; Wang, M.; Chee, C.; Stepkowski, S. Transplant. Proc. 1994, 26, 3021-3024.
9. (f) Tu, Y.; Stepkowski, S. M.; Chou, T.-C.; Kahan, B. D. Transplantation 1995, 59, 177-183.
10. (a) Tanaka, H.; Kuroda, A.; Marusawa, H.; Hatanaka, H.; Kino, T.; Goto, T.; Hashimoto, M.; Taga, T. J. Am. Chem. Soc. 1987, 109, 5031-5033.
11. (b) Kino, T.; Hatanaka, H.; Hashimoto, M.; Nishiyama, M.; Goto, T.; Okuhara, M.; Kohsaka, M.; Aoki, H.; Imanaka, H. J. Antibiot. 1987, 40, 1249-1255.
12. (a) Van Duyne, G. D.; Standaert, R. F.; Schreiber, S. L.; Clardy, J. J. Am. Chem. Soc. 1991, 113, 7433-7434.
13. (b) Van Duyne, G. D.; Standaert, R. F.; Karplus, P. A.; Schreiber, S. L.; Clardy, J. Science 1991, 252, 839-842.
14. (c) Van Duyne, G. D.; Standaert, R. F.; Karplus, P. A.; Schreiber, S. L.; Clardy, J. J. Mol. Biol. 1993, 229, 105-124.
15. Although several FKBPs binding rapamycin and FK506 have been identified, in this article we refer only to FKBP12, as it is the immunophilin mediating the immunosuppressive effect of FK506 and, most likely, also of rapamycin (see ref 15a).
16. Schreiber, S. L. Science 1991, 251, 283-287.
17. (a) Siekierka, J. J.; Hung, S. H. Y.; Poe, M.; Lin, C. S.; Sigal, N. H. Nature 1989, 341, 755-757.
18. (b) Harding, M. W.; Galat, A.; Uehling, D. E.; Schreiber, S. L. Nature 1989, 341, 758-760.
19. (c) Standaert, R. F.; Galat, A.; Verdine, G. L.; Schreiber, S. L. Nature 1990, 346, 671-674.
20. Bierer, B. E.; Mattila, P. S.; Standaert, R. F.; Herzenberg, L. A.; Burakoff, S. J.; Crabtree, G.; Schreiber, S. L. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 9231-9235.
21. Bierer, B. E.; Somers, P. K.; Wandless, T. J.; Burakoff, S. J.; Schreiber, S. L. Science 1990, 250, 556-559.
22. Dumont, F. J.; Staruch, M. J.; Koprak, S. L.; Siekierka, J. J.; Lin. C. S.; Harrison, R.; Sewell, T.; Kindt, V. M.; Beattie, T. R.; Wyvratt, M.; Sigal, N. H. J. Exp. Med. 1992, 176, 751-760.
23. (a) Dumont, F. J.; Staruch, M. J.; Koprak, S. L.; Melino, M. R.; Sigal, N. H. J. Immunol. 1990, 144, 251-258
24. (b) Dumont, F. J.; Melino, M. R.; Staruch, M. J.; Koprak, S. L.; Fischer, P. A.; Sigal, N. H. J. Immunol. 1990, 144, 1418-1424.
25. (a) Schreiber, S. L.; Liu, J.; Albers, M. W.; Rosen, M. K.; Standaert, R. F.; Wandless, T. J.; Somers, P. K. Tetrahedron 1992, 48, 2545-2558.
26. (b) Rosen, M. K.; Schreiber, S. L. Angew. Chem., Int. Ed. Engl. 1992, 31, 384-400.
27. (c) Schreiber, S. L. Cell 1992, 70, 365-368.
28. (d) Schreiber, S. L.; Albers, M. W.; Brown, E. J. Acc. Chem. Res. 1993, 26, 412-420.
29. (e) Belshaw, P. J.; Meyer, S. D.; Johnson, D. D.; Romo, D.; Ikeda, Y.; Andrus, M.; Alberg, D. G.; Schultz, L. W.; Clardy, J.; Schreiber, S. L. Synlett 1994, 381-392.
30. (a) Liu. J.; Farmer, J. D., Jr.; Lane, W. S.; Friedman, J.; Weissman, I.; Schreiber, S. L. Cell 1991, 66, 807-815.
31. (b) Liu, J.; Albers, M. W.; Wandless, T. J.; Luan, S.; Alberg, D. G.; Belshaw, P. J.; Cohen, P.; MacKintosh, C.; Klee, C. B.; Schreiber, S. L. Biochemistry 1992, 31, 3896-3901.
32. (c) Fruman, D. A.; Klee, C. B.; Bierer, B. E.; Burakoff, S. J. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 3686-3690.
33. (d) Clipstone, N. A.; Crabtree, G. R. Nature 1992, 357, 695-697.
34. (e) O'Keefe, S. J.; Tamura, J.; Kincaid, R. L.; Tocci, M. J.; O'Neill, E. A. Nature 1992 357, 692-694.
35. (a) Brown, E. J.; Albers, M. W.; Shin, T. B.; Ichikawa, K.; Keith, C. T.; Lane, W. S.; Schreiber, S. L. Nature 1994, 369, 756-758.
36. (b) Sabatini, D. M.; Erdjument-Bromage, H.; Lui, M.; Tempst, P.; Snyder, S. H. Cell 1994, 78, 35-43.
37. (c) Chiu, M. I.; Katz, H.; Berlin, V. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 12574-12578.
38. (d) Sabers, C. J.; Martin, M. M.; Brunn, G. J.; Williams, J. M.; Dumont, F. J.; Wiederrecht, G.; Abraham, R. T. J. Biol. Chem. 1995, 270, 815-822.
39. (e) Chen, Y.; Chen, H.; Rhoad, A. E.; Warner, L.; Caggiano, T. J.; Failli, A.; Zhang, H.; Hsiao, C.-L.; Nakanishi, K.; Molnar-Kimber, K. L. Biochem. Biophys. Res. Commun. 1994, 203, 1-7.
40. Ocain, T. D.; Longhi, D.; Steffan, R. J.; Caccese, R. G.; Sehgal, S. N. Biochem. Biophys. Res. Commun. 1993, 192, 1340-1346.
41. 28-O-Methylrapamycin (2) was prepared in three steps from rapamycin 1: (a) selective monosilylation of C40-OH with 1.1 equiv of TBSOTf and 2.2 equiv of 2,6-lutidine in methylene chloride at 0 °C (83%); (b) methylation of C28-OH using 3 equiv of trimethyloxonium tetrafluo-roborate in the presence of 5 equiv proton sponge in methylene chloride at room temperature (60%) (ref 18); (c) desilylalion in 18:1 acetonitrile - HF·-pyridine at 0 °C (51%).
42. (a) Diem, M. J.; Burow, D. F.; Fry, J. L. J. Org. Chem. 1977, 42, 1801-1802.
43. (b) Evans, D. A.; Miller, S. J.; Ennis, M. D.; Ornstein, P. L. J. Org. Chem. 1992, 57, 1067-1069.
44. (c) Evans, D. A.; Ratz, A. M.; Huff, B. E.; Sheppard, G. S. Tetrahedron Lett. 1994, 35, 7171-7172.
45. 9
46. 3H-thymidine-incorporation, a measure for cell proliferation, is determined.
47. Messerschmidt, A.; Pflugrath, J. W. J. Appl. Crystallogr. 1987, 306-315.
48. Brunger, A.; Krukowski, A.; Erikson, J. J. Acta Crystallogr. 1990, A46, 585-593.
49. Jones, A. T.; Zou, J.-Y.; Cowan, S. W.; Kjeldgaard, M. J. Acta Crystallogr. 1991, A47, 110-119.